SCHEMBL30984742

SCHEMBL30984742

Nc1ccc(N2CCN(CC3CC4(CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 15/20 0.61
▸ DDB1 Q16531 7/20 0.56
▸ AR P10275 4/20 0.48
▸ BTK Q06187 2/20 0.46
▸ ALK Q9UM73 1/20 0.46
▸ CDK9 P50750 1/20 0.45
▸ IKZF3 Q9UKT9 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ OPRM1 P35372 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ IRAK1 P51617 1/20 0.44
▸ IRAK4 Q9NWZ3 1/20 0.44
▸ IRAK3 Q9Y616 1/20 0.44
▸ PLK4 O00444 1/20 0.43
▸ TNF P01375 1/20 0.43
▸ IL1B P01584 1/20 0.43
▸ TBXA2R P21731 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984709 0.95 CRBN (0.59) CRBNDDB1ARBTKALK
SCHEMBL30984978 0.91 CRBN (0.62) CRBNDDB1ARBTKCDK9
SCHEMBL29986989 0.90 CRBN (0.66) CRBNDDB1ARBTKCDK9
SCHEMBL24299348 0.90 CRBN (0.66) CRBNDDB1ARBTKCDK9
SCHEMBL30984808 0.89 CRBN (0.59) CRBNDDB1ARALKCDK9
SCHEMBL27397986 0.89 CRBN (0.64) CRBNDDB1ARBTKALK
SCHEMBL30984987 0.87 CRBN (0.64) CRBNDDB1ARBTKIKZF3
SCHEMBL30400867 0.86 CRBN (0.80) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL25172415 0.86 CRBN (0.80) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29928079 0.85 CRBN (0.61) CRBNDDB1ARBTKALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146502-A1 WEE1 DEGRADING COMPOUNDS BEIJING NEOX BIOTECH LIMITED (CN) 2024-07-11 — — WO disclosed
Send feedback